SEC Form 4 · accession 0001209191-19-015550
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pritesh Shah
Officer — Chief Commercial Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 4, 2019 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 1, 2019 | M | 7,439 | $11.46 | A | 32,678 | D | |
| Ordinary SharesF2 | Mar 1, 2019 | S | 4,127 | $55.233 | D | 28,551 | D | |
| Ordinary SharesF3 | Mar 1, 2019 | S | 3,312 | $56.111 | D | 25,239 | D | |
| Ordinary SharesF1 | Mar 1, 2019 | M | 16,250 | $7.15 | A | 41,489 | D | |
| Ordinary SharesF4 | Mar 1, 2019 | S | 8,733 | $55.227 | D | 32,756 | D | |
| Ordinary SharesF5 | Mar 1, 2019 | S | 7,517 | $56.097 | D | 25,239 | D | |
| Ordinary SharesF1 | Mar 1, 2019 | M | 16,897 | $21.15 | A | 42,136 | D | |
| Ordinary SharesF6 | Mar 1, 2019 | S | 9,161 | $55.233 | D | 32,975 | D | |
| Ordinary SharesF7 | Mar 1, 2019 | S | 7,736 | $56.094 | D | 25,239 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF8 | $11.46 | Mar 1, 2019 | M | 7,439 | D | — | Feb 24, 2026 | Ordinary Shares | 7,439 | 24 | D |
| Options to Buy Ordinary SharesF8 | $7.15 | Mar 1, 2019 | M | 16,250 | D | — | Feb 21, 2027 | Ordinary Shares | 16,250 | 18,514 | D |
| Options to Buy Ordinary SharesF8 | $21.15 | Mar 1, 2019 | M | 16,897 | D | — | Feb 26, 2028 | Ordinary Shares | 16,897 | 45,961 | D |
Explanation of responses
- F1Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.
- F2On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 4,127 shares in multiple trades at prices ranging from $54.64 to $55.61. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F3On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 3,312 shares in multiple trades at prices ranging from $55.72 to $56.55. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F4On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 8,733 shares in multiple trades at prices ranging from $54.62 to $55.61. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F5On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 7,517 shares in multiple trades at prices ranging from $55.62 to $56.56. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F6On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 9,161 shares in multiple trades at prices ranging from $54.62 to $55.61. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F7On March 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 7,736 shares in multiple trades at prices ranging from $55.62 to $56.57. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F8Options exercised were fully vested as of the date hereof.